Correlation Between Vertex Pharmaceuticals and Synopsys

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Synopsys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Synopsys into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals and Synopsys, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Synopsys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Synopsys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Synopsys.

Diversification Opportunities for Vertex Pharmaceuticals and Synopsys

  Correlation Coefficient

Modest diversification

The 3 months correlation between Vertex and Synopsys is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Synopsys in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synopsys and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Synopsys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synopsys has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Synopsys go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and Synopsys

Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to generate 1.04 times less return on investment than Synopsys. But when comparing it to its historical volatility, Vertex Pharmaceuticals is 1.28 times less risky than Synopsys. It trades about 0.04 of its potential returns per unit of risk. Synopsys is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  25,424  in Synopsys on September 10, 2022 and sell it today you would earn a total of  7,151  from holding Synopsys or generate 28.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
ValuesDaily Returns

Vertex Pharmaceuticals  vs.  Synopsys

 Performance (%) 
Vertex Pharmaceuticals 
Vertex Performance
5 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Vertex Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2023.

Vertex Price Channel

Synopsys Performance
0 of 100
Over the last 90 days Synopsys has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Synopsys is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Synopsys Price Channel

Vertex Pharmaceuticals and Synopsys Volatility Contrast

   Predicted Return Density   

Pair Trading with Vertex Pharmaceuticals and Synopsys

The main advantage of trading using opposite Vertex Pharmaceuticals and Synopsys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Synopsys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synopsys will offset losses from the drop in Synopsys' long position.
Vertex Pharmaceuticals vs. Verizon Communications
Vertex Pharmaceuticals vs. International Business Machines
Vertex Pharmaceuticals vs. Johnson Johnson
Vertex Pharmaceuticals vs. Microsoft
The idea behind Vertex Pharmaceuticals and Synopsys pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Synopsys vs. General Electric
Synopsys vs. Procter Gamble
Synopsys vs. Intel
Synopsys vs. Alcoa Corp
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bond Directory
Find actively traded corporate debentures issued by US companies